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Background: a number of studies have examined the outcome of complex wound and graft infections, but most include
small numbers of patients collected over a prolonged period of time. To date, there is little information on the clinical
outcome of infections involving methicillin-resistant Staphylococcus aureus (MRSA).
Methods: between February 1998 and January 1999, two prospective multi-centre audits were performed in order to
examine the current outcomes following (1) complex vascular wound infections and (2) graft infections in Britain and
Ireland with particular reference to outcome associated with MRSA infection.
Results: seventy-five complex wound infections (Szylagyi II and III) were reported, with the commonest single organism
being MRSA. Type II infections were associated with a 5% risk of death and/or amputation as opposed to 75% in those
with a type III infection. Fifty-five graft infections were reported, with the commonest single organism being MRSA.
Overall, 30 (55%) died or underwent amputation. MRSA wound and graft infections were associated with a significantly
higher risk of amputation and prolonged hospital stay (but not of death) as compared with MRSA negative patients.
Conclusions: in this audit, MRSA was the commonest single organism cultured in patients with complex wound and
graft infections after vascular surgery. This represents a major change in the spectrum of causative organisms relative
to other, older published series. MRSA infections contribute towards an increased risk of adverse outcome and prolonged
hospital stay.
Introduction to vascular practice.4 The current paper reports the
clinical outcomes of two separate audits performed
The Joint Vascular Research Group (JVRG) undertook between 1st February 1998 and 31st January 1999.
The first evaluated outcome in patients with complexa multi-centre audit of the outcome following (1) com-
plex wound infections and (2) graft infections in wound infections, while the second specifically aud-
ited outcome in patients with infected grafts.patients undergoing treatment of arterial disease in
participating vascular centres in Great Britain and
Ireland. The impetus was increasing concern about
the emergence and clinical relevance of methicillin- Complex wound infection audit
resistant Staphylococcus aureus (MRSA) and, in par-
ticular, the suspicion that MRSA infections were as- In 1972, Szylagyi developed the classification of wound
sociated with a higher morbidity and mortality.1–3 infection in vascular surgical practice which stands
to this day.5 According to this classification, wound
infections were graded after appropriate clinical and/
or other assessment as being type I if they only in-Materials and Methods
volved the overlying skin (e.g. superficial cellulitis).
Type II infections involved the skin and subcutaneousThe Joint Vascular Research Group (JVRG) comprises
tissues but not the underlying graft (e.g. wound nec-25 vascular centres in Great Britain and Ireland who
rosis and subcutaneous tissue infection followingcollaborate on a broad range of clinical trials relating
femoro-distal bypass but with no involvement of the
deep graft). Type III infections involved the skin, sub-
∗ Please see Appendix on p. 294 for a list of abbreviations used in cutaneous tissues and the underlying graft (e.g. graft
the article. exposed at base of infected wound/abscess, wound† Please address all correspondence to: A. R. Naylor, Consultant
vascular surgeon, Department of Surgery, Leicester Royal Infirmary. infection with anastomotic false aneurysm, wound
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Table 1. Baseline patient data.infection with anastomotic haemorrhage). In Szylagi’s
original report, type I infections were deemed to be Wound infection Graft infection
(n=75) (n=55)of no clinical importance.5 Accordingly, the JVRG chose
to audit outcome in the more complex wound in-
Aortic reconstruction 16 (21%) 17 (31%)fections (Szylagi type II and III). Infra-inguinal bypass (vein) 20 (27%) 4 (7%)
Infra-inguinal bypass 15 (20%) 12 (22%)
(prosthetic)
Infra-inguinal bypass 5 (7%) 5 (9%)
(composite)Graft infection audit Extra-anatomic bypass 5 (7%) 12 (22%)
Carotid endarterectomy 2 (3%) 0 (0%)
Carotid-subclavian bypass 0 (0%) 1 (2%)The second study audited the outcome of patients
False aneurysm repair 2 (3%) 3 (5%)presenting between 1 February 1998 and 31 January Femoral embolectomy 2 (3%) 1 (2%)
1999 with a clinical and/or radiological diagnosis of Post-angioplasty abscess 1 (1%) 0 (0%)
Major limb amputation 7 (9%) 0 (0%)an infected graft. By definition, patients diagnosed as
Male:female 43:32 33:22having a Szylagi type III infection in the complex Consultant: SpR primary 45:30 41:14
wound infection audit were also included in the graft operator
Elective:non-elective primary 36:39 30:25infection audit.
procedure
Pre-existing diabetes mellitus 23 (31%) 15 (28%)
Pre-existing digital ulcer 20 (27%) 14 (25%)
Pre-existing tissue loss 12 (16%) 4 (7%)
Known to be MRSA +ve 9 (12%) 6 (11%)Data acquisition
pre-op
Participating centres were asked to complete a stand-
ardised audit form 30 days following diagnosis (if the Table 2. Microbiology.
patient was discharged within this time period) or
Wound infection Graft infectionfollowing completion of hospital treatment if the dur-
(n=65)∗,∗∗ (n=55)∗ation of stay was >30 days. The audit was anonymous
in order to maximise participation. Accordingly, no Methicillin-resistant S. aureus 27 (40%) 18 (33%)
Methicillin-sensitive S. aureus 10 (15%) 11 (20%)record was maintained of those centres which par-
Coliforms 24 (36%) 17 (31%)ticipated nor of the total number of arterial procedures Skin flora inc S. epidermidis 10 (15%) 4 (7%)
performed during the period of study. As with pre- Pseudomonas aeruginosa 5 (7%) 1 (2%)
Strep. milleri 2 (3%) 5 (9%)vious multi-centre studies, the authors accept that
Candida infection 0 (0%) 1 (2%)there is no way of knowing if all wound or graft No growth 3 (5%)
infections were reported during the study period, but
∗ Some patients had more than one organism cultured.each JVRG centre was contacted three times during
∗∗ In 10 patients the responsible organism was omitted from thethe year to maximise awareness. Statistical analyses audit form.
were performed using Mann–Whitney U-test for con-
tinuous data and Fisher’s Exact test for discrete data.
cultures of Staphylococcus aureus from infected wounds
were methicillin-resistant. Eleven of the 16 type III
wound infections (69%) yielded either MRSA (n=8)
or MSSA (n=3). Nine patients (12%) were known toResults
have a positive culture for MRSA in foot ulcers or
digital/heel gangrene prior to surgery.Wound infection audit
First-line management of type II infections included
systemic antibiotic therapy alone in 54 patients (72%),Seventy-five audit forms were submitted (Table 1).
Eleven patients (15%) destined to develop a type II or 18 (24%) underwent formal wound debridement and
packing while three (4%) underwent antibiotic ir-III wound infection had apparently not received any
prophylactic antibiotics at the time of surgery. The rigation or insertion of gentamycin beads.
Table 3 summarises the risks of death and majorreason for this is unknown but may simply reflect a
failure to complete the form properly. The remainder amputation in the wound infection audit. Overall, 20%
of patients died or underwent amputation with thereceived augmentin (co-amoxiclav) or a cephalosporin
(±metronidazole). Table 2 summarises the organisms worst prognosis being observed in patients with a
type III infection. Patients with type III wound in-cultured from the infected wounds. The commonest
single organism was MRSA (40%). Overall, 73% of fections were significantly more likely to die (44% vs.
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Table 3. The wound infection audit: mortality and amputation rates.
Parameter Number Death Amputation Death and/or amputation (%)
All patients 75 10 8 15 (20)
Type II infections 59 3 1 3 (5)
Type III infections 16 7 7 12 (75)
MRSA +ve (all) 27 5 6 9 (33)
MRSA −ve (all) 48 5 2 6 (13)
MRSA +ve (all) 27 5 6 9 (33)
MSSA (all) 10 3 0 3 (30)
Non-SA (all) 38 2 2 3 (8)
MRSA type II 19 3 1 3 (16)
MSSA type II 7 0 0 0 (0)
Non-SA type II 33 0 0 0 (0)
MRSA type III 8 2 5 6 (75)
MSSA type III 3 3 0 3 (100)
Non-SA type III 5 2 2 3 (60)
Vein grafts/patches 21 1 1 2 (10)
Dacron grafts/patches 24 3 1 3 (13)
PTFE grafts/patches 18 3 6 7 (39)
No grafts 12 3 0 3 (25)
Aortic operations 16 3 1 3 (19)
Infra-inguinal (vein) 20 1 1 1 (5)
Infra-inguinal (prosth) 20 3 6 8 (40)
All others 19 3 0 3 (16)
5%, p=0.0005) or undergo amputation (44% vs. 2%, stay (median 28, range 12–93) than MRSA −ve type
II infections (median 18, range 7–68, p<0.003). A similarp<0.0001) than patients with type II infections (Table
3). phenomenon was noted in type III infections (MRSA
+ve median hospital stay 45 days, range 31–155;Table 3 also shows that patients with MRSA +ve
wound infections were significantly more likely to die MRSA −ve median 20, range 0–24, p<0.001).
or undergo amputation than patients with MRSA−ve
infections (33% vs. 13%, p=0.039). This was primarily
because MRSA +ve patients were more likely to
undergo amputation (22% vs. 4%, p=0.022) as there
was no significant association between MRSA positive Graft infection audit
wound infection and death (18% vs. 10%, p=0.48). An
adverse outcome (death or amputation) was sig- Fifty-five graft infection forms were submitted, in-
cluding the 16 with a type III wound infection reportednificantly more likely in infra-inguinal reconstructions
involving prosthetic material as opposed to vein (40% earlier. Four patients (7%) had apparently not received
any prophylactic antibiotics prior to surgery. Thevs. 5%, p=0.019), but this was principally due to
MRSA infection of the Dacron or PTFE. Of the nine reasons for not administering prophylactic antibiotics
were not documented, but may reflect incompletepatients known to have a positive MRSA culture prior
to surgery, none apparently received prophylactic van- form filling. The remainder received augmentin (co-
amoxiclav), a cephalosporin or metronidazole. Tablecomycin or teicoplanin and three (33%) ultimately
required a major limb amputation. 2 summarises the organisms cultured from the infected
grafts. The commonest single cultured organism wasOverall, the median duration of hospital stay was
significantly longer in (i) diabetics (median 38 days, MRSA (33%) and 18/29 (62%) of cultures of Staphy-
lococcus aureus were methicillin-resistant. Six patientsrange 9–155) than non-diabetics (median 23, range
0–81, p=0.006), (ii) patients with type III infections (11%) were known to be MRSA +ve prior to per-
forming the original procedure and five either died(median 44, range 0–155) as opposed to type II (median
20, range 7–93, p=0.011) and (iii) patients with MRSA or required amputation following surgery. Of the 18
MRSA+ve graft infections, one involved a vein graft,+ve wound cultures (median 32, range 18–155) com-
pared to MRSA −ve wound cultures (median 20, six infected a Dacron graft, 10 a PTFE graft, while one
patient had a primary MRSA infection of the commonrange 0–140, p<0.001). Finally, patients with MRSA
+ve type II wound infections had a longer hospital femoral artery. The latter case is noteworthy in that a
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Table 4. The graft infection audit: mortality and amputation rates.
Parameter Number Death Amputation Death and/or amputation (%)
All patients 55 17 18 30 (55)
Early type III 16 7 7 12 (75)
All others 39 10 11 18 (46)
MRSA +ve 18 4 11 13 (72)
MRSA −ve 37 13 4 17 (46)
MRSA +ve 18 4 11 13 (72)
MSSA 11 5 1 6 (55)
Others 26 8 6 11 (42)
Non-elective 30 10 10 18 (60)
Elective 25 7 8 12 (48)
Vein 4 1 1 1 (25)
Dacron 26 10 5 13 (50)
PTFE 21 3 11 13 (62)
No graft 4 3 1 3 (75)
Aortic 17 8 2 8 (47)
Lower limb∗ 37 9 16 22 (59)
TGE 26 10 9 17 (65)
PGE 8 3 3 4 (50)
Others 21 4 6 9 (43)
∗ Lower limb refers to infections involving infra-inguinal bypasses, extra-anatomic bypasses, femoral false aneurysm repairs and femoral
endarterectomies.
massive groin haemorrhage occurred following dis- a significantly longer hospital stay (median 46 days
(range 12–155)) as compared with non-MRSA in-ruption of the primary arterial closure and again three
days later from a dehisced vein patch. fections (median 20 days (range 0–209) (p=0.042)).
Otherwise, there was no significant association be-Seventeen patients (31%) presented with occult signs
of infection (fevers, rigors etc.) while nine (16%) pre- tween the type of primary operation, concurrent dis-
ease or age and the duration of hospital stay.sented with a purulent discharging wound. An emer-
gency presentation was documented in 25 (45%)
patients (haemorrhage, blood-stained discharge, rap-
idly enlarging false aneurysm, graft occlusion) while Discussion
four forms (7%) failed to document the presentation.
Primary management entailed no active intervention The current audit was prompted by an increasing
number of anecdotal comments and reports amongstin three patients (5%), formal debridement in 16 (29%),
primary amputation in two (4%), partial graft excision vascular surgeons in Great Britain and Ireland that
MRSA infections were associated with worse clinicalwith revascularisation in eight (15%) and total graft
excision with revascularisation in 26 (47%). outcomes relative to other organisms. The aim of the
study was firstly to provide baseline data on theTable 4 summarises the risks of death and am-
putation relative to the presence/absence of MRSA, incidence of MRSA in complex wound and graft in-
fections and, secondly, to determine whether MRSAgraft type, urgency of operation, aortic vs. infra-in-
guinal reconstructions and type of operation. Overall, infections were indeed associated with a worse clinical
outcome.55% of patients with a graft infection died or required
a major limb amputation despite active treatment. Szylagi developed the classification of vascular
wound infections that stands to this day.1 In his originalMRSA +ve graft infections were not associated with
a significantly increased risk of death (22% vs. 35%, paper, he concluded that only those infections which
involved the graft were of clinical importance. One ofp=0.37), but they were associated with a significantly
higher risk of major limb amputation (61% vs. 11%, the inevitable problems regarding the interpretation
of papers on graft infection is the fact that they usuallyp=0.005) when compared to patients with MRSA−ve
graft infections. Interestingly, the risk of death and or involve single centre experience over a long period of
time, primarily because of the relative rarity of graftamputation was not related to the urgency or type of
primary operation (aortic/infra-inguinal etc). infection as a whole. In the past, the principal or-
ganisms cultured from infected grafts were pre-Patients with an MRSA-positive graft infection had
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dominantly MSSA, Staphylococcus epidermidis and col- A similar phenomenon was observed in patients
iforms.5,6 To date, no large-scale recent audits have presenting with a graft infection. As before, MRSA
focussed on the emergence of MRSA in vascular prac- was the single most commonly cultured organism.
tice. MRSA graft infections were not associated with an
MRSA was first described in 1961,4 but its clinical increased risk of death (Table 4) but were associated
impact has only really been recognised in the last 5 with a significant increase in the risk of amputation
years. In 1990 the Communicable Disease Surveillance and prolonged hospital stay. Once again, the available
Centre (CDSC) in Britain reported methicillin re- evidence suggests that graft excision and primary
sistance in 1.7% of Staphylococcus aureus cultures. By amputation was the principal therapeutic strategy once
1998, however, the proportion had increased to 34%. the surgeon knew that he/she was dealing with an
Currently, 8000+ positive blood isolates for MRSA MRSA graft infection.
are reported each year in England and Wales to the It has been suggested that MRSA is no more virulent
CDSC.5 Interestingly, there have been no parallel in- than MSSA.10 Although this may be true in the strictest
creases in the numbers of resistant Escherichia coli and term of the definition of virulence, the principal prob-
Streptococcus pneumoniae during the same time period.8 lem remains that MRSA is not sensitive to the vast
Prior to 1994, no MRSA graft infections had been majority of antibiotics and it can therefore proliferate
encountered in the vascular unit at Leicester Royal unchecked. For example, vancomycin was never meant
Infirmary. However, since then 16 have been treated. to be the front-line antibiotic for the treatment of
Overall, nine (56%) died, including all of those having Staphylococcus aureus infections, but it is now the first-
undergone an open aortic procedure. Most worrying line drug for the treatment of MRSA. In this respect,
was the observation that neither autogenous vein nor it is ominous to note that vancomycin-resistant strains
native artery was a barrier to MRSA.9 Similar adverse of MRSA are now emerging.11
outcomes have been observed in the vascular units at The proliferation of MRSA has been attributed to
Leicester General Hospital (two), Bradford (one) and poor ward hygiene, an increasing proportion of com-
St. Mary’s Hospital, London (three). Of the 15 infra- plex and sick patients, prolonged ITU stay, excessive
inguinal bypasses infected with MRSA at St. Mary’s, antibiotic usage and the fact that no new classes of
10 required major limb amputation and four died of antibiotics have emerged since the 1960s.9,12 Methicillin
MRSA sepsis.3 resistance has also been attributed to excessive anti-
The current audit suggests that MRSA may now be biotic usage, but MRSA can occur as epidemic strains
the predominant organism in complex wound and which are not simply the original hospital bacteria
graft infections in Britain and Ireland and is associated that have become resistant. Evidence suggests thatwith a poor clinical outcome. This represents a major
methicillin resistance may have a significant geneticchange in the spectrum of micro-organisms cultured
component.12previously. This audit has also shown that those in-
It should, however, be conceded that the currentfections that remain localised to the skin and sub-
study has a number of important flaws that couldcutaneous tissues have a relatively low risk of death
confound meaningful interpretation. A number ofor amputation (5%) as opposed to 75% for those with
forms failed to detail the responsible micro-organism,a type III infection (p<0.0001). Overall, patients with
especially in the wound infection audit, and this mayMRSA +ve wound infections had a significantly
have biased the results in favour of MRSA. Second,higher risk of major limb amputation and prolonged
despite our best efforts at publicising the study, somehospital stay than MRSA−ve patients. It is interesting
surgeons may not have reported all of the infectionsto note that the presence of MRSA was not associated
occurring in their practice. This is, however, a re-with a significantly higher risk of death (Table 3). The
cognised problem with any multi-centre audit. Third,evidence from this audit suggests that once the surgeon
because the audit was anonymous, we have no waybecame aware of the presence of MRSA (particularly
of knowing how many of the JVRG centres actuallyfollowing progression to a type III infection in a patient
participated, nor of the actual incidence of complexwith a prosthetic infra-inguinal bypass), the primary
wound or graft infection relative to the number oftreatment appeared to be graft excision plus primary
procedures undertaken. It may be, for example, thatamputation with the aim of preserving life rather than
colleagues preferentially reported cases involvinglimb. One lesson for the future may be to advocate
MRSA. At the outset, the JVRG decided that themore aggressive debridement and coverage of type II
reporting of adverse outcomes would be best achievedinfections, particularly if they involve MRSA. In this
if the audit were anonymous.series, 72% of type II infections were initially treated
by systemic antibiotics alone. Finally, we have no way of knowing when the
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for Vascular Surgery. Eds: J. J. Earnshaw, J. A. Murie. TFM PublishingMRSA infection actually occurred. It may be that late
Ltd. 1999, Shropshire, U.K. (pp 207–209).colonisation with MRSA was inevitable (and therefore
possibly clinically irrelevant) in long stay patients with
complex wound infections who otherwise had the
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MRSA=methicillin-resistant Staphylococcus aureus; MRSA +ve=
patients with a positive culture for MRSA; MRSA −ve=patients
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PTFE=polytetrafluoroethylene; SpR=senior vascular trainee; Non-
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